{"id":"https://openalex.org/W4379282948","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps4198","title":"Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) pathogenic variants: SWOG S2001.","display_name":"Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) pathogenic variants: SWOG S2001.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379282948","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps4198"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.tps4198","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps4198","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps4198","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.TPS4198?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.TPS4198?role=tab","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022022603","display_name":"Vincent M. Chung","orcid":"https://orcid.org/0000-0001-9475-808X","observed_orcids":["https://orcid.org/0000-0001-9475-808X"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent Chung","raw_affiliation_strings":["City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048654505","display_name":"Katherine Adams Guthrie","orcid":"https://orcid.org/0000-0001-7257-8280","observed_orcids":["https://orcid.org/0000-0001-7257-8280"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine A Guthrie","raw_affiliation_strings":["Fred Hutchiinson Cancer Research Center, and SWOG Statistics and Data Management Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchiinson Cancer Research Center, and SWOG Statistics and Data Management Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021453899","display_name":"Michael Jon Pishvaian","orcid":"https://orcid.org/0000-0002-1165-9041","observed_orcids":["https://orcid.org/0000-0002-1165-9041"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J Pishvaian","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Washington, DC","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104332585","display_name":"Kim Anna Reiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kim Anna Reiss","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089839809","display_name":"Andrew M. Lowy","orcid":"https://orcid.org/0000-0002-7106-0735","observed_orcids":["https://orcid.org/0000-0002-7106-0735"]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew M. Lowy","raw_affiliation_strings":["UC San Diego Moores Cancer Center, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC San Diego Moores Cancer Center, La Jolla, CA","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065605420","display_name":"Davendra P. S. Sohal","orcid":"https://orcid.org/0000-0002-0182-8403","observed_orcids":["https://orcid.org/0000-0002-0182-8403"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davendra Sohal","raw_affiliation_strings":["University of Cincinnati, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061252089","display_name":"Sarah Colby","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Colby","raw_affiliation_strings":["SWOG Statistical Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SWOG Statistical Center, Seattle, WA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022594161","display_name":"Elad Sharon","orcid":"https://orcid.org/0000-0002-0044-9719","observed_orcids":["https://orcid.org/0000-0002-0044-9719"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elad Sharon","raw_affiliation_strings":["Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069843364","display_name":"Carmen Joseph Allegra","orcid":"https://orcid.org/0000-0001-6402-2709","observed_orcids":["https://orcid.org/0000-0001-6402-2709"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carmen Joseph Allegra","raw_affiliation_strings":["Cancer Therapy Evaluation Program, Division of Cancer Treatment & Diagnosis, National Cancer Institute of the National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Therapy Evaluation Program, Division of Cancer Treatment & Diagnosis, National Cancer Institute of the National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076438320","display_name":"Eileen Mary O'Reilly","orcid":"https://orcid.org/0000-0002-8076-9199","observed_orcids":["https://orcid.org/0000-0002-8076-9199"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eileen Mary O'Reilly","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019995834","display_name":"Elena Gabriela Chiorean","orcid":"https://orcid.org/0000-0003-3306-9592","observed_orcids":["https://orcid.org/0000-0003-3306-9592"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Gabriela Chiorean","raw_affiliation_strings":["University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053703913","display_name":"Philip Agop Philip","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307629703","display_name":"Hoag Memorial Hospital Presbyterian","ror":"https://ror.org/05nmfef18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1307629703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip Agop Philip","raw_affiliation_strings":["Hoag Family Cancer Institute, Newport Beach, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoag Family Cancer Institute, Newport Beach, CA","institution_ids":["https://openalex.org/I1307629703"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"TPS4198","last_page":"TPS4198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-pancreatic-ductal-adenocarcinoma","display_name":"metastatic pancreatic ductal adenocarcinoma","score":0.9120000004768372},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8849999904632568},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5889999866485596},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9739999771118164},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.6169999837875366},{"id":"https://openalex.org/keywords/immune-microenvironment","display_name":"immune microenvironment","score":0.49000000953674316},{"id":"https://openalex.org/keywords/sting-pathway","display_name":"STING pathway","score":0.6800000071525574},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.8830000162124634},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.8827768564224243},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.856025218963623},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.7205551266670227},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6656822562217712},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6530839204788208},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.5125186443328857},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.483452171087265},{"id":"https://openalex.org/C2780194787","wikidata":"https://www.wikidata.org/wiki/Q4836333","display_name":"BRCA mutation","level":4,"score":0.4809381365776062},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.422254741191864},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3852730393409729},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.3705747723579407},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.33483389019966125},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.tps4198","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps4198","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps4198","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.TPS4198?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.tps4198","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps4198","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps4198","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.TPS4198?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4379282948.pdf","grobid_xml":"https://content.openalex.org/works/W4379282948.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3126104001","https://openalex.org/W4406869901","https://openalex.org/W7162539097","https://openalex.org/W2609725437","https://openalex.org/W2949055210","https://openalex.org/W4379984508","https://openalex.org/W2883374837","https://openalex.org/W4402560302","https://openalex.org/W2955605139","https://openalex.org/W3121978488"],"abstract_inverted_index":{"TPS4198":[0],"Background:":[1],"Olaparib":[2],"was":[3,110,118],"approved":[4],"in":[5,24,76,112,120,122,212,238,248],"2019":[6],"as":[7,223],"maintenance":[8,224],"therapy":[9],"for":[10,39,170,272,302],"gBRCA1/2+":[11,42,105],"metastatic":[12],"pancreatic":[13],"cancer":[14],"(mPDA)":[15],"patients":[16],"(pts).":[17],"The":[18,202],"POLO":[19,229],"trial":[20,307],"showed":[21],"an":[22],"improvement":[23],"median":[25],"progression":[26],"free":[27],"survival":[28],"(mPFS)":[29],"with":[30,83,114,131,136,216],"olaparib":[31,217,221],"compared":[32],"to":[33,99,187,209,297],"placebo":[34],"(7.4":[35],"vs":[36,193],"3.8":[37],"months)":[38],"platinum":[40],"sensitive":[41],"mPDA":[43,106,129,213],"pts.":[44,107,280],"Preclinical":[45],"studies":[46,75],"have":[47,79,287],"demonstrated":[48],"that":[49],"PARP":[50,87],"inhibitors":[51],"modulate":[52],"the":[53,64,84,102,115,228,239,249],"immune":[54,65,89],"microenvironment":[55],"by":[56],"increasing":[57],"genomic":[58],"instability,":[59],"PD-L1":[60],"expression":[61],"and":[62,117,143,164,195,255,262,278,300],"activating":[63],"inflammatory":[66],"stimulator":[67],"of":[68,86,104,138,151,162,205,235,245,275,282],"interferon":[69],"genes":[70],"(STING)":[71],"pathway.":[72],"Several":[73],"clinical":[74],"solid":[77],"tumors":[78],"shown":[80],"preliminary":[81],"efficacy":[82],"combination":[85],"plus":[88],"checkpoint":[90],"inhibitors.":[91],"Based":[92,226],"upon":[93,227],"these":[94],"data,":[95],"SWOG":[96,121],"S2001":[97,109],"aims":[98],"further":[100],"improve":[101],"PFS":[103,211],"Methods:":[108],"developed":[111],"collaboration":[113],"Alliance":[116],"activated":[119],"December":[123],"2020.":[124],"Key":[125],"eligibility":[126],"criteria":[127],"include:":[128],"pts":[130,180,214,271],"gBRCA1/2":[132],"pathogenic":[133],"variants":[134],"identified":[135],"standard":[137],"care":[139],"germline":[140,171],"genetic":[141],"testing":[142],"progression-free":[144],"after":[145,198],"receiving":[146],"at":[147],"least":[148],"16":[149],"weeks":[150],"platinum-based":[152],"chemotherapy":[153],"(FOLFIRINOX,":[154],"FOLFOX":[155],"or":[156,178],"gemcitabine/cisplatin":[157],"+/-":[158],"nab-paclitaxel).":[159],"One":[160],"cycle":[161],"gemcitabine":[163],"nab-paclitaxel":[165],"is":[166,208],"allowed":[167],"while":[168],"waiting":[169],"testing.":[172],"Zubrod":[173],"performance":[174],"status":[175,197],"(PS)":[176],"0":[177,192],"1":[179],"are":[181,184],"eligible.":[182],"Pts":[183],"stratified":[185],"according":[186],"first":[188],"line":[189,200],"chemotherapy,":[190],"PS":[191],"1,":[194],"disease":[196],"1st":[199],"treatment.":[201],"primary":[203],"objective":[204],"this":[206,266],"study":[207],"compare":[210],"treated":[215],"+":[218],"pembrolizumab":[219],"versus":[220],"alone":[222],"therapy.":[225],"trial,":[230],"we":[231],"expect":[232],"a":[233,243,263,273],"mPFS":[234,244],"7":[236],"months":[237,247,258],"control":[240],"arm.":[241],"Targeting":[242],"11.7":[246],"experimental":[250],"arm":[251],"(hazard":[252],"ratio":[253],"0.6)":[254],"assuming":[256],"15":[257],"follow-up,":[259],"80%":[260],"power":[261],"1-sided":[264],"alpha=0.10,":[265],"design":[267],"requires":[268],"enrolling":[269],"88":[270],"total":[274],"78":[276],"eligible":[277],"evaluable":[279],"As":[281],"February":[283],"2023,":[284],"26":[285],"participants":[286],"been":[288],"accrued.":[289],"Prospective":[290],"serial":[291],"blood":[292],"samples":[293],"will":[294],"be":[295],"collected":[296],"bank":[298],"DNA":[299],"RNA":[301],"future":[303],"correlative":[304],"studies.":[305],"Clinical":[306],"information:":[308],"NCT04548752":[309],".":[310]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-06-05T00:00:00"}